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Liver receptor homologue-1 (LRH-1, NR5A2) 
is a nuclear receptor with sequence homology 
to steroidogenic factor-1 (SF-1, NR5A1) 
(for review see reference 1). In addition to their 
homology, SF-1 and LRH-1 bind to identical 
DNA consensus sequences and are able to bind 
phospholipids (1–5). Apart from these shared 
properties, LRH-1 and SF-1 have a quite dif-
ferential tissue expression pattern and thus likely 
diff  erent functions. SF-1 expression is confi  ned 
to steroidogenic tissues and the hypothalamo–
pituitary–adrenal axis, where it regulates devel-
opment, diff  erentiation, steroidogenesis, and 
sexual determination (1). Although SF-1 is 
abundantly expressed in the adrenals, it is absent 
in the intestinal mucosa. In contrast, LRH-1 is 
expressed in intestine, liver, exocrine pancreas, 
and the ovary where it plays an important role 
in development, reverse cholesterol transport, 
bile acid homeostasis, and steroidogenesis (1). 
In the intestinal mucosa, LRH-1 is predomi-
nantly expressed by crypt cells, where it regu-
lates the expression of cyclin D1 and E1 and 
thereby promotes epithelial cell proliferation 
and crypt cell renewal (6). Consequently, 
LRH-1 has also been implicated in the devel-
opment of colon carcinomas (7).
Glucocorticoids are steroids with important 
immunoregulatory functions (8). Endogenous 
glucocorticoid synthesis is substantially regu-
lated by the transcriptional control of steroi-
dogenic enzymes of the cytochrome P450 gene 
family (CYP genes). Previous studies have 
shown that the nuclear receptors SF-1 and 
LRH-1 are potent regulators of some of these 
genes in the adrenals and ovaries (1, 9–12). Al-
though the adrenals are the most important 
source of glucocorticoids, there is increasing 
evidence for extra-adrenal glucocorticoid syn-
thesis in other organs and tissues (13–15). We 
have recently identifi   ed the intestinal epithe-
lium as a potent source of extra-adrenal gluco-
corticoid synthesis (16). Intestinal glucocorticoid 
production is induced upon immunological 
stress through the induction of steroidogenic 
enzymes. Importantly, intestinal glucocorticoids 
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mediate an important regulatory feed-back loop and critically 
regulate intestinal immune responses. In the absence of intes-
tinal glucocorticoids, antigen-specifi  c T cells become overac-
tivated during viral infections, indicating an immunosuppressive 
role of locally produced glucocorticoids (16).
The factors that regulate intestinal glucocorticoid synthe-
sis are unknown thus far. As LRH-1 and steroidogenic en-
zyme expression is confi  ned to the crypt cells of the intestinal 
mucosa (6, 16), we investigated the role of LRH-1 in the 
regulation of intestinal glucocorticoid synthesis. We show 
here that LRH-1 expression is induced in the intestine upon 
immune stimulation and parallels the induction of the genes 
of the steroidogenic enzymes CYP11A1 and CYP11B1. 
Overexpression of LRH-1 in murine intestinal epithelial cells 
strongly induces the transcriptional activation of these genes 
and promotes the synthesis of corticosterone. Importantly, 
LRH-1 is critical for intestinal glucocorticoid synthesis in 
vivo, as LRH-1 halplo-insuffi   ciency abrogates immune cell–
induced expression of CYP11A1 and CYP11B1 and associ-
ated corticosterone synthesis in the intestinal mucosa. This 
report demonstrates for the fi  rst time that LRH-1 is involved 
in glucocorticoid synthesis. As SF-1 expression is absent in 
the intestinal epithelium, we propose that LRH-1 has a 
unique role in the regulation of extra-adrenal glucocorticoid 
synthesis and immune regulation in the intestinal mucosa.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
LRH-1 expression is induced upon T cell activation 
in the intestinal mucosa
LRH-1, but not SF-1, has been previously reported to be 
abundantly expressed in intestinal crypt cells (6). As the same 
cells also express steroidogenic enzymes and produce the bio-
active glucocorticoid corticosterone (16), we aimed at inves-
tigating the role of LRH-1 in intestinal glucocorticoid 
synthesis. Intestinal steroidogenic enzyme expression and 
glucocorticoid synthesis is induced upon injection of an ago-
nistic T cell–activating anti-CD3 antibody (16). We thus an-
alyzed the expression of LRH-1 in the small intestinal tissue 
from control and anti-CD3–treated mice, and compared it to 
that in adrenal glands. As described previously, LRH-1 ex-
pression levels in the adrenal glands were found to be very 
low (1). In marked contrast, even basal levels of LRH-1 in 
the intestine were >200 times higher than those found in 
adrenals. Interestingly, injection of anti-CD3 resulted in an 
additional threefold induction of intestinal LRH-1 levels 
(Fig. 1). Similarly, infection of mice with the lymphocytic 
choriomeningitis virus caused an up-regulation of intestinal 
LRH-1 and CYP11B1 expression (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20060357/DC1).
LRH-1 promotes expression of steroidogenic enzymes 
and glucocorticoid synthesis
As anti-CD3–mediated increase of intestinal LRH-1 expres-
sion correlated with the induction of intestinal steroidogenic 
enzyme expression and glucocorticoid synthesis (16), we 
  assessed whether LRH-1 overexpression can promote the 
expression and activity of steroidogenic enzymes in the mu-
rine intestinal epithelial cell line mICcl2 that displays crypt-
like features (17). We thus transfected these cells with the 
CYP11A1 or CYP11B1 luciferase reporter constructs in the 
absence or presence of increasing amounts of LRH-1 expres-
sion plasmid. The CYP11A1 gene encodes for P450 ssc, the 
rate-limiting enzyme in the glucocorticoid synthesis convert-
ing cholesterol to pregnenolone, whereas the CYP11B1 gene 
encodes for 11β-hydroxylase, the enzyme catalyzing inactive 
11-deoxycorticosterone to active corticosterone. Ectopic ex-
pression of LRH-1 dose-dependently induced CYP11A1 
promoter activity and resulted in a sixfold increase of basal 
activity. The CYP11B1 promoter was found to be even 
more responsive to induction by LRH-1 and an up to 
25-fold induction could be detected (Fig. 2, A and B). These 
data were confi  rmed by analysis of endogenous CYP11A1 
and CYP11B1 mRNA expression. Transfection of mICcl2 
cells with LRH-1 resulted in a strong increase of endogenous 
levels of both gene transcripts (Fig. 2, C and D).
Most intriguingly, the increase in expression of these key 
enzymes in the glucocorticoid synthesis pathway observed 
after LRH-1 transfection of mICcl2 cells was also accompa-
nied with a robust release of corticosterone (Fig. 2 E). These 
data demonstrate that increased expression of LRH-1 is suffi   -
cient to promote the expression of steroidogenic enzymes 
and thereby trigger the glucocorticoid synthesis in intestinal 
epithelial cells.
Mutation of the LRH-1 response element inhibits 
LRH-1–induced CYP11A1 and CYP11B1 promoter activity
This induction of CYP11A1 and CYP11B1 transcription is 
likely the eff  ect of direct binding to the promoter of these genes 
as putative LRH-1/SF-1 consensus sequences have been iden-
tifi  ed in both the CYP11A1 and CYP11B1 promoters (9, 11, 
18, 19). To confi  rm the importance of these response elements 
in the LRH-1–mediated induction of CYP11A1 and CYP11B1 
promoter activity, we mutated the predicted proximal response 
Figure 1.  LRH-1 expression in intestinal mucosa. Wild-type mice 
were injected with PBS (control) or anti-CD3 antibody (αCD3) for 3 h. 
Small intestinal tissue was isolated and LRH-1 expression was measured 
by quantitative real-time RT-PCR. LRH-1 expression levels in adrenal 
glands isolated from control mice were used for normalization. Mean 
values of LRH-1 expression levels ± SD normalized to adrenals of three 
mice per group are shown.JEM VOL. 203, September 4, 2006  2059 
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element in the two promoter reporter constructs. In agreement 
with the notion that LRH-1 directly acts on these promoters 
via binding to these response elements, we observed an almost 
complete inhibition of LRH-1–induced CYP11A1 and CYP11B1 
promoter activity (Fig. 3).
Endogenous LRH-1 promotes basal CYP11A1 
and CYP11B1 promoter activity
As LRH-1 is abundantly expressed in normal intestinal epi-
thelial cells and overexpression of LRH-1 strongly promotes 
corticosterone synthesis in mICcl2 cells, we next investigated 
whether endogenous expression of LRH-1 may be responsi-
ble for induction of basal CYP11A1 and CYP11B1 promoter 
activities in mICcl2 cells. Cells were thus transfected with 
CYP11A1 and CYP11B1 promoter reporter constructs and 
a dominant negative LRH-1 expression vector (DN LRH-1) 
comprising the DNA binding domain, but lacking the   ligand-
dependent transactivation domain. Competition of DNA 
binding of DN LRH-1 with endogenous LRH-1 dramati-
cally inhibited basal CYP11A1 promoter activity and still 
substantially down-regulated basal CYP11B1 promoter ac-
tivity (Fig. 4). These data suggest that endogenous LRH-1 
expression levels contribute to basal expression levels of ste-
roidogenic enzymes in intestinal epithelial cells.
Critical role of LRH-1 in intestinal glucocorticoid 
synthesis in vivo
We next investigated the role of endogenous LRH-1 in the 
induction of intestinal glucocorticoid synthesis in vivo using 
the LRH-1 halplo-insuffi   cient  (LRH-1+/−) mouse model 
(6). LRH-1 is critical for embryonic development; homozy-
gous LRH-1–defi  cient mice die in utero (6, 20, 21), whereas 
LRH-1+/− mice are viable and develop normally, allowing 
the investigation of LRH-1 in vivo. To study the role of 
LRH-1 in the regulation of intestinal glucocorticoid synthe-
sis in vivo, we used the previously established model of 
anti-CD3–induced steroid synthesis (16). LRH-1+/+ and 
LRH-1+/− mice were treated with PBS control or anti- 
CD3 antibody leading to strong T cell activation and sub-
sequent intestinal glucocorticoid synthesis. As predicted, 
injection of anti-CD3 antibody substantially induced intesti-
nal expression levels of LRH-1 in the small and large bowel 
of wild-type animals, but not of LRH-1 haplo-insuffi   cient 
animals (Fig. 5). In agreement with the expected role of 
LRH-1 in the regulation of steroidogenic enzymes, we also 
observed a strong anti-CD3–mediated induction of CYP11A1 
Figure 2.  LRH-1 induces steroidogenic enzyme expression and 
glucocorticoid synthesis. (A and B) The murine intestinal epithelial cell 
line mICcl2 was transfected with the murine CYP11A1 (A) or CYP11B1 
(B) promoter reporter construct and increasing amounts of LRH-1 expres-
sion plasmid. Luciferase activity was measured and normalized to 
CYP11A1 and CYP11B1 reporter construct alone, respectively. Mean values 
of triplicates ± SD of a typical experiment out of three are shown. (C and D) 
mICcl2 cells were transfected with pCMX (control) or pCMX-LRH-1 (LRH-1) 
(1 μg) and endogenous CYP11A1 (C) and CYP11B1 mRNA expression 
was measured by real-time RT-PCR. Mean values of triplicates ± SD of 
a typical experiment out of three are shown. (E) mICcl2 cells were trans-
fected as described before and corticosterone was measured in the super-
natant after 16 h. Mean values of triplicates ± SD of a typical experiment 
out of three are shown.
Figure 3.  Mutation of LRH-1 response element inhibits LRH-1–
induced CYP11A1 and CYP11B1 promoter activity. mICcl2 cells were 
cotransfected with wild-type or mutant CYP11A1 (A) or CYP11B1 (B) re-
porter constructs (1 μg each), respectively, and control plasmid or LRH-1 
expression plasmid (1 μg each). Luciferase activity was measured and 
normalized to wild-type CYP11A1 and CYP11B1 reporter construct alone, 
respectively. Mean values of triplicates ± SD of a typical experiment out 
of two are shown.2060  LRH-1 AND INTESTINAL GLUCOCORTICOID SYNTHESIS | Mueller et al. 
and CYP11B1 expression in tissue from small and large intes-
tine of wild-type animals, which was substantially reduced in 
the intestinal tissue isolated from LRH-1+/− animals (Fig. 5). 
Finally, ex vivo–cultured small intestinal tissue from anti-
CD3–treated LRH-1+/+ mice resulted in a strong release 
of metyrapone-inhibitable corticosterone, as measured by 
  radioimmunoassay (RIA). In marked contrast, no anti-CD3–
driven increase in glucocorticoid synthesis was observed in 
the intestinal mucosa of LRH-1+/− mice (Fig. 5).
These fi  ndings show that LRH-1 is a central transcription 
factor for the expression of steroidogenic enzymes and the 
synthesis of corticosterone in the murine intestinal tissue. 
  Importantly, although LRH-1 has already previously been 
implicated in the regulation of sex steroid synthesis pathways 
(e.g., by regulating the expression of CYP11A1 in granulosa 
cells of the ovary) (22), the present study represents to our 
knowledge the fi  rst report that demonstrates the involvement 
of LRH-1 in the synthesis of glucocorticoids. In the adrenal 
glands, regulation of glucocorticoid synthesis appears to be 
critically dependent on SF-1 (23). SF-1 defi  ciency results in 
the absence of adrenal glands and consequently in the absence 
of systemic glucocorticoids in the adult animal (for review see 
reference 24). As LRH-1 is only expressed at minimal levels in 
the adrenal glands, it is likely that LRH-1 cannot compensate 
for the lack of SF-1 in this organ. Accordingly, LRH-1+/− 
mice have normal serum glucocorticoid levels. Although 
SF-1–defi  cient mice lack adrenals and gonads, they have nor-
mal CYP11A1 expression in the placenta, indicating that 
LRH-1 may regulate placental CYP11A1 expression (12). 
Quite surprising is the observation that, although adult SF-1–
defi  cient animals lack serum glucocorticoids, they have nor-
mal serum levels at the embryonic stage, demonstrating that 
other extra-adrenal sources contribute to the synthesis of sys-
temic glucocorticoids (12). Based on our fi  ndings that LRH-1 
critically regulates intestinal glucocorticoid synthesis, it is 
tempting to speculate that the embryonic intestinal mucosa 
may also secrete glucocorticoids into the blood stream in an 
LRH-1–dependent manner. In agreement with this notion, 
it was reported that CYP11A1 is expressed in the embryonic 
gut in the absence of SF-1 (25). Clearly, in the adult animal, 
SF-1 expression is absent in the intestinal epithelium and 
LRH-1 appears to represent the main regulator of intestinal 
glucocorticoid synthesis.
Figure 4.  Endogenous LRH-1 promotes basal CYP11A1 and 
CYP11B1 promoter activity. mICcl2 cells were cotransfected with 
CYP11A1 (A) or CYP11B1 (B) reporter constructs, and control plasmid or 
dominant negative LRH-1 (DN LRH-1) expression plasmid. The inhibition 
of basal promoter activity of triplicates ± SD of a typical experiment is 
shown (n = 3).
Figure 5.  Endogenous LRH-1 expression is required for intestinal 
expression of steroidogenic enzymes and glucocorticoid synthesis 
in vivo. Wild-type LRH-1+/+ mice and heterozygous LRH-1+/− mice were 
injected with PBS (ctrl) or anti-CD3 antibody (αCD3) for 3 h. Small and 
large intestinal tissues were isolated and LRH-1, CYP11A1, and CYP11B1 
expression was measured by real-time RT-PCR and normalized to GAPDH. 
In addition, small intestinal tissue from control or anti-CD3–treated mice 
was cultured ex vivo for 6 h and corticosterone (Cort.) in the cell-free 
supernatant was measured by RIA as described in Materials and methods. 
Mean values ± SD of three mice per group of a typical experiment out of 
two are shown. *, P < 0.05.JEM VOL. 203, September 4, 2006  2061 
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LRH-1 likely regulates intestinal glucocorticoid synthesis 
not only at the level of CYP11A1 and CYP11B1 transcrip-
tion. As LRH-1 and SF-1 have an overlapping target pattern, 
it is expected that also the expression of other steroidogenic 
enzymes may be regulated, directly or indirectly, by LRH-1. 
In addition, as SF-1 controls the availability of cholesterol by 
inducing the expression of steroidogenic acute regulatory 
protein (StAR), LRH-1 may similarly regulate steroid syn-
thesis at the substrate level (cholesterol). A recent fi  nding by 
Kim et al. supports this idea by demonstrating a role for 
LRH-1 in StAR expression in granulosa cells (22).
LRH-1 not only plays a critical role in the regulation of 
extra-adrenal intestinal glucocorticoid synthesis but also pro-
motes intestinal epithelial cell renewal (i.e., by inducing the 
expression of the cell cycle proteins cyclin D1 and E1) (6). 
Although epithelial cell renewal and glucocorticoid synthesis 
have little in common at a fi  rst glance, there may be a link 
  between these two LRH-1–regulated processes. Strong 
T cell activation and associated immunological responses in 
the intestinal mucosa lead to the release of proinfl  ammatory 
cytokines, such as IFNγ and TNFα, which impair the intesti-
nal epithelial barrier function (26). Similarly, T cell–mediated 
cytotoxicity can cause epithelial cell apoptosis (27) and 
thereby also leads to increased permeability of the epithelial 
layer. The resulting leakiness of the epithelial layer usually 
results in an increased stimulation of immune cells by luminal 
bacterial products, which further accelerates destructive in-
fl  ammatory responses in the gut. Induction and activation of 
LRH-1 may not only reduce the epithelial layer leakiness and 
stimulation of immune cells by increasing epithelial cell re-
newal but may also control immune cell activation by the 
regulating intestinal glucocorticoid synthesis. We therefore 
suggest that LRH-1 plays an important role in the regulation 
of intestinal immune homeostasis.
MATERIALS AND METHODS
Cells and reagents. The murine intestinal epithelial cell line mICcl2 has been 
described previously (17). The culture medium consisted of Dulbecco’s modi-
fi   ed Eagle medium/Ham’s F-12 12g/L (1:1, vol/vol, GIBCO BRL), 
NaHCO3 2.438g/L, 2% steroid-free FCS, 60 nmol/L sodium selenate, 
5 μg/ml apo-transferrin, 10 ng/ml murine EGF, 1 nmol/L triiodothyronine, 
5 μg/ml insulin, 2 mmol/L l-alanyl-l-glutamine, 20 mmol/L Hepes, 100 U/ml 
penicillin, and 100 μg/ml streptomycin. The glucocorticoid synthesis inhib-
itor metyrapone was obtained from Sigma-Aldrich.
Plasmids. The expression construct for wild-type murine LRH-1 
(pCMX-LRH-1) has been described previously (28). For the cloning of the 
dominant negative expression vector for murine LRH-1 (DN-LRH-1),
cDNA sequences corresponding to aa 1–282 of mouse LRH-1 were 
PCR-amplifi   ed with primers 5′-G  G  A  A  T  T  C  T  T  C  G  C  T  A  A  G  A  A  T  G  T-
C  T  G  C  T  A  G  T  -3′ and 5′-G  G  A  A  T  T  C  T  C  A  G  T  G  A  C  C  A  T  A  G  G  G  T  T  G  G-
T  A  A  C  C  A  -3′ from pCMX-LRH-1 and the amplifi   cation product was 
subsequently cloned into the EcoRI site of pCMX. For the promoter re-
porter constructs, 1.7 kb of the 5′-fl  anking region of the murine CYP11A1 
  (accession no. 13070) and CYP11B1 (accession no. NT 082172.1) genes 
were amplifi  ed by PCR from C57BL/6 genomic DNA using specifi  c 
primers (CYP11A1 fw 5′-G  C  A  A  G  G  A  T  C  C  T  T  C  C  T  T  C  T  C  A  C  A  A  T  C  C-
T  A  A  G  -3′, rev 5′-G  A  T  C  G  T  C  G  A  C  A  G  T  C  T  T  T  T  A  G  C  C  A  G  C  A  T  A  C  -3′; 
CYP11B1 fw 5′-C  T  A  A  G  G  A  T  C  C  G  T  G  A  T  T  C  T  C  T  G  A  T  G  G  T  C  T  C  T   -3′, 
rev 5′-C  C  T  T  G  T  C  G  A  C  T  T  G  T  C  A  T  C  T  T  C  C  T  C  T  C  T  T  C  C  -3′) and cloned 
into the HsLuc luciferase reporter construct (29) using BamHI and SalI 
restriction sites.
The predicted LRH-1/SF-1 core binding sites (AGGTCA) (19) at 
  positions −138 and −221 of the CYP11A1 and the CYP11B1 promoter, 
respectively, were mutated (to taaTCA) by site-directed mutagenesis using 
a mutagenesis kit (Quick Change; Stratagene) and the following primers: 
mut mCYP11A1 fw 5′-GGGtaaTCACCG-3′, mut mCYP11A1 rev 
5′-CGGTGAttaCCC-3′; mut mCYP11B1 fw 5′-ACCTGAaatCAG-3′, 
mut mCYP11B1 rev 5′-CTGattTCAGGT-3′.
CYP11A1 and CYP11B1 promoter assay. CYP11A1 or CYP11B1 wild-
type and mutated reporter constructs, and β-galactosidase expression vector for 
transfection control, were cotransfected into mICcl2 cells using the calcium 
phosphate precipitation method. In some experiments, cells were cotransfected 
with diff  erent amounts of a wild-type or dominant negative murine LRH-1 
expression vector. After overnight transfection, cells were washed and cultured 
for 16 h before lysis of the cells. β-galactosidase and luciferase activity assays 
were performed as described previously (30).
Induction and measurement of intestinal glucocorticoid synthesis. 
Intestinal glucocorticoid synthesis was induced as previously described (16). 
In brief, age- and sex-matched wild-type LRH+/+ mice or heterozygous 
LRH-1+/− mice in the C57BL/6 background (6, 7) were injected i.p. with 
either PBS or 50 μg of anti–mouse CD3 antibody i.p. After 4 h, mice were 
killed and small intestinal tissue was isolated and cultured in the presence or 
absence of the glucocorticoid synthesis inhibitor metyrapone (200 μg/ml) 
for 6 h. After that, cell-free supernatant was harvested and corticosterone was 
measured by RIA. Results were expressed as the diff  erence between samples 
cultured without metyrapone and samples cultured with metyrapone 
(metyrapone-inhibitable corticosterone synthesis) to correct for variable con-
tamination with serum glucocorticoids. All animal experiments have been 
reviewed and approved by the review board of the State of Bern.
In some experiments, control or LRH-1–transfected mICcl2 cells were cul-
tured for 16 h and corticosterone in cell-free supernatant was measured by RIA.
Detection of CYP11A1, CYP11B1, and LRH-1 mRNA by real-time 
RT-PCR. Small and large intestinal tissue from PBS or anti-CD3–injected 
LRH-1+/+ or LRH-1+/− mice, or control or LRH-1–transfected mICcl2 
cells were lysed in TRI reagent (Sigma-Aldrich) and RNA was isolated. 
RNA was DNase treated and 2 μg of RNA were reverse transcribed us-
ing a Taqman Gold RT kit obtained from Applied Biosystems. Real-time 
PCR was performed in an Applied Biosystems Real-time PCR 7500 ma-
chine using SYBR green and the following primers: mCYP11A1 forward 
5′-C  C  A  G  C  C  C  A  A  C  A  T  T  A  C  C  G  A  G  A  T  -3′, reverse 5′-G  A  C  T  T  C  A  G  C  C  C-
G  C  A  G  C  A  T  -3′; mCyp11B1 forward 5′-C  A  A  T  A  G  A  A  G  C  T  A  G  C  C  A  C  T  T-
T  G  T  -3′, reverse 5′-A  G  G  G  T  G  T  G  G  A  G  G  A  A  C  T  T  C  A  G  -3′. For mLRH-1 
and the house-keeping gene GAPDH amplifi  cation Quantitec primer   assays 
obtained from QIAGEN were used. GAPDH was used to normalize 
CYP11A1, CYP11B1, and LRH-1 expression levels.
Statistical analysis. In some experiments, diff   erences between groups 
were analyzed by unpaired Student’s t test. Values of P < 0.05 were consid-
ered signifi  cant.
Online supplemental material. Fig. S1, describing viral infection-
induced LRH-1 and CYP11B1 expression, is available at http://www.jem.
org/cgi/content/full/jem.20060357/DC1.
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